Prognostic Value of Tissue-Type Plasminogen Activator (tPA) and Its Complex With the Type-1 Inhibitor (PAI-1) in Breast Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6690353
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Regulation of Programmed Cell Death by Plasminogen Activator Inhibitor Type 1 (PAI-1)

Thrombosis and Haemostasis
Hematology
2008English

Highly Stable Plasminogen Activator Inhibitor Type One (VLHL PAI-1) Protects Fibrin Clots From Tissue Plasminogen Activator-Mediated Fibrinolysis

International Journal of Molecular Medicine
MedicineGenetics
2007English

Human Visceral Adipose Tissue and the Plasminogen Activator Inhibitor Type 1

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2007English

External Quality Assessment of Trans-European Multicentre Antigen Determinations (Enzyme-Linked Immunosorbent Assay) of Urokinase-Type Plasminogen Activator (uPA) and Its Type 1 Inhibitor (PAI-1) in Human Breast Cancer Tissue Extracts

British Journal of Cancer
Cancer ResearchOncology
1998English

Cathepsin-D, Urokinase Plasminogen Activator and Type-1 Plasminogen Activator Inhibitor in Early Breast Cancer: An Immunohistochemical Study of Prognostic Value and Relations to Tenascin-C and Other Factors

British Journal of Cancer
Cancer ResearchOncology
1999English

Structural and Functional Peculiarities of Plasminogen Activator Inhibitor PAI-1

Biopolymers and Cell
BiochemistryGeneticsMolecular Biology
2010English

Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population

PLoS ONE
Multidisciplinary
2015English

RFLP for SST I (Sac I) at the Human Plasminogen Activator Inhibitor Type 1 (PAI-1) Gene Locus

Nucleic Acids Research
Genetics
1989English

Thrombin and Plasmin Generation in Patients With Plasminogen or Plasminogen Activator Inhibitor Type 1 Deficiency

Haemophilia
MedicineGeneticsHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy